Literature DB >> 16492855

Postoperative upper airway obstruction after recovery of the train of four ratio of the adductor pollicis muscle from neuromuscular blockade.

Matthias Eikermann1, Manfred Blobner, Harald Groeben, Christopher Rex, Thomas Grote, Markus Neuhäuser, Martin Beiderlinden, Jürgen Peters.   

Abstract

Anesthetics, and even minimal residual neuromuscular blockade, may lead to upper airway obstruction (UAO). In this study we assessed by spirometry in patients with a train-of-four (TOF) ratio >0.9 the incidence of UAO (i.e., the ratio of maximal expiratory flow and maximal inspiratory flow at 50% of vital capacity [MEF50/MIF50] >1) and determined if UAO is induced by neuromuscular blockade (defined by a forced vital capacity [FVC] fade, i.e., a decrease in values of FVC from the first to the second consecutive spirometric maneuver of > or =10%). Patients received propofol and opioids for anesthesia. Spirometry was performed by a series of 3 repetitive spirometric maneuvers: the first before induction (under midazolam premedication), the second after tracheal extubation (TOF ratio: 0.9 or more), and the third 30 min later. Immediately after tracheal extubation and 30 min later, 48 and 6 of 130 patients, respectively, were not able to perform spirometry appropriately because of sedation. The incidence of UAO increased significantly (P < 0.01) from 82 of 130 patients (63%) at preinduction baseline to 70 of 82 patients (85%) after extubation, and subsequently decreased within 30 min to values observed at baseline (80 of 124 patients, 65%). The mean maximal expiratory flow and maximal inspiratory flow at 50% of vital capacity ratio after tracheal extubation was significantly increased from baseline (by 20%; 1.39 +/- 1.01 versus 1.73 +/- 1.02; P < 0.01), and subsequently decreased significantly to values observed at baseline (1.49 +/- 0.93). A statistically significant FVC fade was not present, and a FVC fade of > or =10% was observed in only 2 patients after extubation. Thus, recovery of the TOF ratio to 0.9 predicts with high probability an absence of neuromuscular blocking drug-induced UAO, but outliers, i.e., persistent effects of neuromuscular blockade on upper airway integrity despite recovery of the TOF ratio, may still occur.

Entities:  

Mesh:

Year:  2006        PMID: 16492855     DOI: 10.1213/01.ane.0000195233.80166.14

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  18 in total

Review 1.  [Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies].

Authors:  T Fuchs-Buder; M Eikermann
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

Review 2.  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.

Authors:  Ana-Marija Hristovska; Patricia Duch; Mikkel Allingstrup; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2017-08-14

3.  Neuromuscular blockade improves surgical conditions (NISCO).

Authors:  Manfred Blobner; Christiane G Frick; Roland B Stäuble; Hubertus Feussner; Stefan J Schaller; Christoph Unterbuchner; Charlotte Lingg; Martina Geisler; Heidrun Fink
Journal:  Surg Endosc       Date:  2014-08-15       Impact factor: 4.584

Review 4.  Obstructive Sleep Apnea-a Perioperative Risk Factor.

Authors:  Philipp Fassbender; Frank Herbstreit; Matthias Eikermann; Helmut Teschler; Jürgen Peters
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

5.  Neuromuscular Block and Blocking Agents in 2018.

Authors:  Christoph Unterbuchner
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01

6.  Pre-Operative Ability of Clinical Scores to Predict Obstructive Sleep Apnea (OSA) Severity in Susceptible Surgical Patients.

Authors:  E Deflandre; S Degey; J-F Brichant; A-F Donneau; R Frognier; R Poirrier; V Bonhomme
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

Review 7.  Epidural anesthesia and pulmonary function.

Authors:  Harald Groeben
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

8.  Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents.

Authors:  Friederike Haerter; Jeroen Cedric Peter Simons; Urs Foerster; Ingrid Moreno Duarte; Daniel Diaz-Gil; Shweta Ganapati; Katharina Eikermann-Haerter; Cenk Ayata; Ben Zhang; Manfred Blobner; Lyle Isaacs; Matthias Eikermann
Journal:  Anesthesiology       Date:  2015-12       Impact factor: 7.892

9.  Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.

Authors:  Mark Welliver; John McDonough; Nicholas Kalynych; Robert Redfern
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

Review 10.  Perioperative medical management of patients with COPD.

Authors:  Marc Licker; Alexandre Schweizer; Christoph Ellenberger; Jean-Marie Tschopp; John Diaper; François Clergue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.